BridgeBio, BMS Set Sail In Expanded SHP2 Collaboration

BridgeBio and BMS announced an expansion to their partnership to develop SHP2 inhibitor BBP-398 • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

More from Anticancer

More from Therapeutic Category